Literature DB >> 31132884

Discovery of vascular Rho kinase (ROCK) inhibitory peptides.

Reza Abbasgholizadeh1,2, Hua Zhang1, John W Craft1,2, Robert M Bryan3, Steven J Bark1, James M Briggs1, Robert O Fox1, Anton Agarkov4, Warren E Zimmer5, Scott R Gilbertson4, Robert J Schwartz1,2.   

Abstract

Keywords:  Drug design; Rho kinase inhibitor; kinase activation loop; peptide discovery; phage display

Mesh：

Substances：

Year:  2019        PMID： 31132884      PMCID： PMC6690139          DOI： 10.1177/1535370219849581

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN： 1535-3699


× No keyword cloud information.
  58 in total

1.  Use and properties of ROCK-specific inhibitor Y-27632.

Authors:  S Narumiya; T Ishizaki; M Uehata
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  The carboxy-terminal pleckstrin homology domain of ROCK interacts with filamin-A.

Authors:  Kozue Ueda; Yasutaka Ohta; Hiroshi Hosoya
Journal:  Biochem Biophys Res Commun       Date:  2003-02-21       Impact factor: 3.575

3.  Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop.

Authors:  K Ohashi; K Nagata; M Maekawa; T Ishizaki; S Narumiya; K Mizuno
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

Review 4.  Rho/Rho-kinase mediated signaling in physiology and pathophysiology.

Authors:  Nina Wettschureck; Stefan Offermanns
Journal:  J Mol Med (Berl)       Date:  2002-09-07       Impact factor: 4.599

Review 5.  Rho family-associated kinases PAK1 and rock.

Authors:  Hiroshi Maruta; Thao V Nheu; Hong He; Yumiko Hirokawa
Journal:  Prog Cell Cycle Res       Date:  2003

6.  Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro.

Authors:  Geerten P van Nieuw Amerongen; Pieter Koolwijk; Amanda Versteilen; Victor W M van Hinsbergh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

7.  Molecular cloning, expression, purification, and characterization of soluble full-length, human interleukin-3 with a baculovirus-insect cell expression system.

Authors:  Hongbiao Ding; Carsten Griesel; Manfred Nimtz; Harald S Conradt; Herbert A Weich; Volker Jäger
Journal:  Protein Expr Purif       Date:  2003-09       Impact factor: 1.650

8.  Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice.

Authors:  Tsuyoshi Hattori; Hiroaki Shimokawa; Midoriko Higashi; Junko Hiroki; Yasushi Mukai; Hiroyuki Tsutsui; Kozo Kaibuchi; Akira Takeshita
Journal:  Circulation       Date:  2004-04-19       Impact factor: 29.690

9.  Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart.

Authors:  Kazuhiro Yamamoto; Tohru Masuyama; Yasushi Sakata; Nagahiro Nishikawa; Toshiaki Mano; Junichi Yoshida; Takeshi Miwa; Motoaki Sugawara; Yukihiro Yamaguchi; Tomomi Ookawara; Keiichiro Suzuki; Masatsugu Hori
Journal:  Cardiovasc Res       Date:  2002-07       Impact factor: 10.787

10.  Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin.

Authors:  Yinglin Liu; Yuichiro J Suzuki; Regina M Day; Barry L Fanburg
Journal:  Circ Res       Date:  2004-08-05       Impact factor: 17.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.